DexCom Inc (DXCM):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:DexCom Inc (DXCM) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7366
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:56
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
DexCom Inc (DexCom) is a medical device company that performs design, development and commercialization of continuous glucose monitoring systems for ambulatory and in-hospital use. The company’s major products include DexCom G4, DexCom G4 Platinum and other continuous glucose monitoring systems. DexCom’s in-hospital product, GlucoClear, is a blood-based in-vivo automated glucose monitoring system. It also provides training and support services. DexCom offer its products to endocrinologists, physicians, diabetes educators and others. The company distributes its products in the US, Canada, Australia, New Zealand, Europe, Asia, Latin America and the Middle East through direct sales force and a network of distributors. DexCom is headquartered in San Diego, California, the US.

DexCom Inc (DXCM) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
DexCom Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
DexCom Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
DexCom Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
DexCom Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
DexCom Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
DexCom Inc, Medical Equipment, Deal Details 12
Venture Financing 12
DexCom Raises USD7.2 Million in Venture Financing 12
TypeZero Technologies Raises Funds through Seed Financing 13
Partnerships 14
TypeZero Technologies and EOFlow Enter into Licensing Agreement 14
Senseonics Enters into Licensing Agreement with TypeZero Tech 15
Cellnovo Enters into Licensing Agreement with TypeZero Tech 16
Tandem Diabetes Care Enters into Licensing Agreement with TypeZero Technologies 17
Dexcom Amends Licensing Agreement with Google Life Sciences 18
Tandem Expands Licensing Agreement With Dexcom For Glucose Monitoring System 19
Tandem Diabetes Amends Licensing Agreement With DexCom 20
Novo Nordisk Forms Partnership with Dexcom and Glooko 21
Terumo Enters into Distribution Agreement with DexCom 22
DexCom Enters into Agreement with Eli Lilly 23
Fitbit Forms Partnership with DexCom 24
Senseonics Holdings Enters into Agreement with TypeZero and Roche Diabetes 25
Ascensia Diabetes Care Enters into Agreement with DexCom 26
Apple Enters into Agreement with DexCom 27
Tandem Diabetes Care Enters into Co-Development Agreement with Dexcom 28
Glooko Enters into Agreement with Dexcom 29
Julphar Enters Into Co-Marketing Agreement With Dexcom 30
Debt Offering 31
DexCom Raises USD350 Million in Private Placement of 0.75% Notes Due 2022 31
Acquisition 32
DexCom Acquires TypeZero Technologies 32
DexCom to Acquire Nintamed 33
DexCom Completes Acquisition Of SweetSpot Diabetes Care For Up To USD8.5 Million 34
DexCom Inc – Key Competitors 35
DexCom Inc – Key Employees 36
DexCom Inc – Locations And Subsidiaries 37
Head Office 37
Other Locations & Subsidiaries 37
Recent Developments 38
Financial Announcements 38
Aug 01, 2018: DexCom Reports Second Quarter 2018 Financial Results 38
Feb 27, 2018: DexCom Reports Record Fourth Quarter and Fiscal Year 2017 Financial Results 39
Nov 01, 2017: DexCom Reports Record Third Quarter 2017 Financial Results 41
Aug 01, 2017: DexCom Reports Second Quarter 2017 Financial Results 42
May 02, 2017: DexCom Reports First Quarter 2017 Financial Results 43
Feb 28, 2017: DexCom Reports Fourth Quarter and Fiscal Year 2016 Financial Results 44
Jan 10, 2017: DexCom Reports Record Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2016 and Provides Initial 2017 Outlook 45
Corporate Communications 46
Aug 01, 2018: DexCom Executive Chairman and Director Terry Gregg Retires 46
Mar 13, 2017: DexCom Appoints Richard Collins to Board of Directors 47
Legal and Regulatory 48
Jun 05, 2018: Federal Court Judge Awards AgaMatrix Attorneys’ Fees While Admonishing Dexcom for “Bad Faith” Lawsuit 48
Product News 49
Aug 21, 2017: New Study Shows People with Type 2 Diabetes Benefit from Continuous Glucose Monitoring 49
Jun 09, 2017: New Study Shows Adults with Type 1 and Type 2 Diabetes on Multiple Daily Injections Benefit from CGM 50
Other Significant Developments 52
Sep 19, 2017: DexCom Opens Data Platform and Launches Developer Program to Fuel Diabetes App Innovation 52
Sep 07, 2017: Fitbit and Dexcom to Develop Continuous Glucose Monitoring Experience for People Living with Diabetes 53
Jun 01, 2017: Glooko and Dexcom Expand Relationship With Global Cloud Sharing Data Agreement 54
May 08, 2017: Dexcom Continuous Glucose Monitoring now available on the Government Subsidy Initiative 55
Appendix 56
Methodology 56
About GlobalData 56
Contact Us 56
Disclaimer 56

List of Tables
DexCom Inc, Medical Equipment, Key Facts, 2017 2
DexCom Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
DexCom Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
DexCom Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
DexCom Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
DexCom Inc, Deals By Market, 2012 to YTD 2018 9
DexCom Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
DexCom Raises USD7.2 Million in Venture Financing 12
TypeZero Technologies Raises Funds through Seed Financing 13
TypeZero Technologies and EOFlow Enter into Licensing Agreement 14
Senseonics Enters into Licensing Agreement with TypeZero Tech 15
Cellnovo Enters into Licensing Agreement with TypeZero Tech 16
Tandem Diabetes Care Enters into Licensing Agreement with TypeZero Technologies 17
Dexcom Amends Licensing Agreement with Google Life Sciences 18
Tandem Expands Licensing Agreement With Dexcom For Glucose Monitoring System 19
Tandem Diabetes Amends Licensing Agreement With DexCom 20
Novo Nordisk Forms Partnership with Dexcom and Glooko 21
Terumo Enters into Distribution Agreement with DexCom 22
DexCom Enters into Agreement with Eli Lilly 23
Fitbit Forms Partnership with DexCom 24
Senseonics Holdings Enters into Agreement with TypeZero and Roche Diabetes 25
Ascensia Diabetes Care Enters into Agreement with DexCom 26
Apple Enters into Agreement with DexCom 27
Tandem Diabetes Care Enters into Co-Development Agreement with Dexcom 28
Glooko Enters into Agreement with Dexcom 29
Julphar Enters Into Co-Marketing Agreement With Dexcom 30
DexCom Raises USD350 Million in Private Placement of 0.75% Notes Due 2022 31
DexCom Acquires TypeZero Technologies 32
DexCom to Acquire Nintamed 33
DexCom Completes Acquisition Of SweetSpot Diabetes Care For Up To USD8.5 Million 34
DexCom Inc, Key Competitors 35
DexCom Inc, Key Employees 36
DexCom Inc, Subsidiaries 37

List of Figures
DexCom Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
DexCom Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
DexCom Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
DexCom Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
DexCom Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
DexCom Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
DexCom Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
DexCom Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[DexCom Inc (DXCM):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Abeome Corp-製薬・医療分野:企業M&A・提携分析
    Summary Abeome Corp (Abeome) is a biotechnology company that discovers diagnostic monoclonal antibodies and therapeutic antibodies. The company's pipeline components include PCSK9 to treat hypercholesterolemia; IL-17A to treat psoriasis and inflammation diseases, IL-17F to treat autoimmune diseases, …
  • Karolinska University Hospital:製薬・医療:M&Aディール及び事業提携情報
    Summary Karolinska University Hospital (KUH), a subsidiary of Karolinska Institutet is a healthcare service provider that offers patient care, research and education programs. The hospital offers cross border medical care by referring patients or by tele medicine and health care at a distance. It of …
  • Development Center for Biotechnology:製薬・医療:M&Aディール及び事業提携情報
    Summary Development Center for Biotechnology (DCB) is a non profit organization that offers support to biotechnology and pharmaceutical companies. The organization develops biotech industry through its cooperation and industrialization, key technologies, infrastructure building, research and develop …
  • MegaChips Corp (6875):企業の財務・戦略的SWOT分析
    MegaChips Corp (6875) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • RP Management LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary RP Management LLC (RP Management) is a life sciences financing company that offers biopharmaceutical products. The company’s products include thalomid, myozyme, lexiscan, rituxan, atripla, lyrica, prezista, letairis, januvia, onglyza, neupogen, rotateq, cubicin, savella, and others. It also …
  • Holidaybreak Ltd:企業の戦略・SWOT・財務情報
    Holidaybreak Ltd - Strategy, SWOT and Corporate Finance Report Summary Holidaybreak Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Oi S.A.:企業の戦略・SWOT・財務情報
    Oi S.A. - Strategy, SWOT and Corporate Finance Report Summary Oi S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Soil Machine Dynamics Ltd:企業の戦略的SWOT分析
    Soil Machine Dynamics Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Sensus Healthcare Inc (SRTS):製品パイプライン分析
    Summary Sensus Healthcare Inc (Sensus), previously Sensus Healthcare LLC, designs, manufactures, and markets proprietary medical devices for the treatment of various types of cancers and skin diseases. The company offers superficial radiation therapy (SRT) technology based non-surgical treatment opt …
  • CH2M HILL Companies, Ltd.:戦略・SWOT・企業財務分析
    CH2M HILL Companies, Ltd. - Strategy, SWOT and Corporate Finance Report Summary CH2M HILL Companies, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • UbiQ Bio BV-製薬・医療分野:企業M&A・提携分析
    Summary UbiQ Bio BV (UbiQ) is a biotechnology company that develops and commercializes ubiquitinated peptides and assays that enables drug discovery in Ubiquitin field. The company provides products such as ubiquitin-proteasome system, high throughput screening assay reagents and ubiquitinated polyp …
  • Cracker Barrel Old Country Store, Inc.:企業の戦略・SWOT・財務分析
    Cracker Barrel Old Country Store, Inc. - Strategy, SWOT and Corporate Finance Report Summary Cracker Barrel Old Country Store, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Solent NHS Trust:企業の戦略的SWOT分析
    Solent NHS Trust - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Yamana Gold Inc.:企業の戦略・SWOT・財務情報
    Yamana Gold Inc. - Strategy, SWOT and Corporate Finance Report Summary Yamana Gold Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Indian Oil Corp Ltd (IOC):石油・ガス:M&Aディール及び事業提携情報
    Summary Indian Oil Corp Ltd (IOCL) is an integrated oil and gas company that carries out exploration and production of oil and natural gas, refining of crude oil, pipeline transportation and marketing of natural gas and petroleum products. The company also produces and markets petrochemicals and has …
  • Mari Petroleum Co Ltd (MARI):企業の財務・戦略的SWOT分析
    Mari Petroleum Co Ltd (MARI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Anika Therapeutics Inc (ANIK):企業の財務・戦略的SWOT分析
    Anika Therapeutics Inc (ANIK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Sharjah Electricity & Water Authority:企業の戦略的SWOT分析
    Sharjah Electricity & Water Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Coor Service Management Holding AB:企業の戦略・SWOT・財務情報
    Coor Service Management Holding AB - Strategy, SWOT and Corporate Finance Report Summary Coor Service Management Holding AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Alios BioPharma Inc-製薬・医療分野:企業M&A・提携分析
    Summary Alios BioPharma Inc (Alios BioPharma), a subsidiary of Janssen Pharmaceuticals Inc is a biopharmaceutical company that discovers and develops novel therapies for treatment of viral diseases. The company offers drugs for the treatment of viral infections such as respiratory syncytial virus, i …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆